2026 data FDA MAUDE openFDA FDA Class II

Assay, Glycosylated Hemoglobin

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §864.7470 (Hematology panel).

FDA MAUDE casebook

openFDA event book Assay, Glycosylated Hemoglobin LIGHT-BOOK · MAUDE

#413 of 1000 · 2,943 reports · 2003–2026

  • BOOK 2,943 reports
  • RANK #413 of 1000
  • DEATH 0 death-typed
  • INJ 26 injury-typed
  • MALF 2,846 malfunction
  • SPAN 2003–2026
  • PEAK 2018: 1,911
  • PHOTO Syringe, Antistick

Nearest event-volume peer: Syringe, Antistick (2 report gap)

Assay, Glycosylated Hemoglobin sits #413 of 1000 among tracked device types with 2,943 MAUDE reports spanning 2003–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports run above the device-type norm

Assay, Glycosylated Hemoglobin carries 96.7% MALFUNCTION-coded reports, 31.9pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 0.9% corpus 30.3% · below corpus mean (-29.4 pp)
  • MALF 96.7% corpus 64.8% · above corpus mean (+31.9 pp)

Lead product-problem code Device Operates Differently Than Expected is 17% of coded problems · Lead manufacturer TOSOH CORPORATION accounts for 86% of manufacturer-tagged reports · Top event location OUTPATIENT DIAGNOSTIC FACILITY is 64% of location-tagged rows .

Assay, Glycosylated Hemoglobin in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Assay, Glycosylated Hemoglobin carries 2,943 MAUDE reports, ranked #413 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 2,846 (96.7%)
Other 52 (1.8%)
Injury 26 (0.9%)
19 (0.6%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,805 (94.3%)
Congenital Anomaly 40 (1.3%)
Death 35 (1.2%)
D 32 (1.1%)
Other 28 (0.9%)
Disability 24 (0.8%)
Required Intervention 4 (0.1%)
Hospitalization 3 (0.1%)
Life Threatening 2 (0.1%)
H 1 (0.0%)
S 1 (0.0%)

Top Product Problems

Device Operates Differently Than Expected 635
Device Operational Issue 465
Device Displays Incorrect Message 448
High Test Results 416
Device Issue 315
Incorrect, Inadequate or Imprecise Result or Readings 247
Mechanical Problem 235
Incorrect Or Inadequate Test Results 195
Nonstandard Device 176
Increase in Pressure 95
Pressure Problem 72
Decrease in Pressure 63
Use of Device Problem 61
Low Test Results 57
Leak/Splash 45
Computer Software Problem 43
Device Ingredient or Reagent Problem 34
Calibration Problem 27
Non Reproducible Results 27
Therapeutic or Diagnostic Output Failure 25

Yearly Trend

03
2003: 1
04
2004: 1
06
2006: 3
07
2007: 5
08
2008: 11
09
2009: 15
10
2010: 4
11
2011: 27
12
2012: 51
13
2013: 193
14
2014: 182
15
2015: 64
16
2016: 29
17
2017: 148
18
2018: 1,911
19
2019: 114
20
2020: 13
21
2021: 7
22
2022: 8
23
2023: 27
24
2024: 39
25
2025: 22
26
2026: 68

Reports in 2025 (22) held close to the prior two-year average of 33.

Related Entities for Assay, Glycosylated Hemoglobin

Event Locations

OUTPATIENT DIAGNOSTIC FACILITY 1,889 (64.2%)
635 (21.6%)
I 229 (7.8%)
OUTPATIENT TREATMENT FACILITY 78 (2.7%)
HOSPITAL 70 (2.4%)
LABORATORY 21 (0.7%)
OTHER 15 (0.5%)
NO INFORMATION 5 (0.2%)
UNKNOWN 1 (0.0%)

Compare TOSOH CORPORATION vs ROCHE DIAGNOSTICS →

Nationwide devices with a comparable report-volume footprint

Assay, Glycosylated Hemoglobin carries zero death-typed MAUDE reports, so the peer set below compares report volume only; both axes are floored at ≥100 reports so the neighborhood stays in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (2,943 here).

Similar death-typed counts

Nearest other device types by death-typed report count (0 here), distinct from the volume row.

Disclaimer: MAUDE figures for Assay, Glycosylated Hemoglobin are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Assay, Glycosylated Hemoglobin; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.